Travers Smith advises Numis and Investec on £34 million capital raising by Alliance Pharma plc
Travers Smith LLP has acted for Numis Securities Limited, as nominated adviser and bookrunner, and Investec Bank plc, as bookrunner, in connection with the £34 million placing of new shares by Alliance Pharma plc ("Alliance") in connection with its acquisition from Janssen Pharmaceutica NV (a member of the Johnson & Johnson group of companies) of the exclusive marketing rights to Nizoral, a medical, anti-dandruff shampoo brand, in Asia-Pacific for total consideration of £60 million.